Skip to main content
Figure 4 | Critical Care

Figure 4

From: Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial

Figure 4

Number of patients without norepinephrine at nine time points during the follow-up. Thirty-two severely burned patients were initially randomized in this clinical trial evaluating the effect of low-dose hydrocortisone on shock duration after burn. Twelve low-dose hydrocortisone-treated patients and 15 patients treated with placebo were finally included in the statistical analysis. The numbers of patients without norepinephrine at nine time points after protocol inclusion are shown. The solid black line corresponds to patients treated with low-dose hydrocortisone. The dashed grey line corresponds to patients treated with placebo. Low-dose hydrocortisone or placebo treatments and follow-up durations are shown. Seventy-two hours after inclusion, the difference of weaned patients between the two groups was evaluated with a Fisher’s exact test.

Back to article page